{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:21:14Z","timestamp":1773127274927,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271755"],"award-info":[{"award-number":["82271755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Development Funds of Peking University People\u2019s Hospital","award":["RDGS2024-04"],"award-info":[{"award-number":["RDGS2024-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09759-1","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:13:31Z","timestamp":1773033211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Memory-biased CD8\u03b1\u03b1\u207a T cells show reduced abundance and phenotypic remodeling in SLE"],"prefix":"10.1007","volume":"74","author":[{"given":"Ziqi","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junru","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"10441","key":"9759_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326\u201338.","journal-title":"Lancet"},{"issue":"17","key":"9759_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. JAMA. 2024;331(17):1480\u201391.","journal-title":"JAMA"},{"issue":"10188","key":"9759_CR3","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332\u201343.","journal-title":"Lancet"},{"issue":"9","key":"9759_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"9759_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2478\/jtim-2024-0013","volume":"12","author":"Z Liu","year":"2024","unstructured":"Liu Z, Liu F, Xie J, Zhao Z, Pan S, Liu D, Xia Z, Liu Z. Recognition of differently expressed genes and DNA methylation markers in patients with Lupus nephritis. J Transl Int Med. 2024;12(4):367\u201383.","journal-title":"J Transl Int Med"},{"key":"9759_CR6","doi-asserted-by":"publisher","first-page":"109031","DOI":"10.1016\/j.clim.2022.109031","volume":"239","author":"K Tenbrock","year":"2022","unstructured":"Tenbrock K, Rauen T. T cell dysregulation in SLE. Clin Immunol. 2022;239:109031.","journal-title":"Clin Immunol"},{"key":"9759_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.immunol.17.1.523","volume":"17","author":"W Ellmeier","year":"1999","unstructured":"Ellmeier W, Sawada S, Littman DR. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu Rev Immunol. 1999;17:523\u201354.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"9759_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011;35(2):161\u20138.","journal-title":"Immunity"},{"issue":"1","key":"9759_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.20745","volume":"52","author":"P Blanco","year":"2005","unstructured":"Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8\u2009+\u2009T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(1):201\u201311.","journal-title":"Arthritis Rheum"},{"key":"9759_CR10","doi-asserted-by":"crossref","unstructured":"Fujita Y, Nakayamada S, Kubo S, Miyazaki Y, Sonomoto K, Tanaka H, Tanaka Y. Association of peripheral CD8(+) T cell activation with disease activity and treatment resistance in systemic lupus erythematosus. RMD Open 2025;11(1):e005122.","DOI":"10.1136\/rmdopen-2024-005122"},{"issue":"12","key":"9759_CR11","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang YT, Tsokos GC. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761\u20136.","journal-title":"J Immunol"},{"issue":"1","key":"9759_CR12","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-020-16636-4","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Adamopoulos IE, Moulton VR, Stillman IE, Herbert Z, Moon JJ, Sharabi A, Krishfield S, Tsokos MG, Tsokos GC. Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun. 2020;11(1):2859.","journal-title":"Nat Commun"},{"issue":"8","key":"9759_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/eji.1830210803","volume":"21","author":"U Moebius","year":"1991","unstructured":"Moebius U, Kober G, Griscelli AL, Hercend T, Meuer SC. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol. 1991;21(8):1793\u2013800.","journal-title":"Eur J Immunol"},{"issue":"7","key":"9759_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/ni.3751","volume":"18","author":"R Ruscher","year":"2017","unstructured":"Ruscher R, Kummer RL, Lee YJ, Jameson SC, Hogquist KA. CD8\u03b1\u03b1 intraepithelial lymphocytes arise from two main thymic precursors. Nat Immunol. 2017;18(7):771\u20139.","journal-title":"Nat Immunol"},{"key":"9759_CR15","doi-asserted-by":"crossref","unstructured":"Park JE, Botting RA, Dom\u00ednguez Conde C, Popescu DM, Lavaert M, Kunz DJ, Goh I, Stephenson E, Ragazzini R, Tuck E et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 2020, 367(6480).","DOI":"10.1126\/science.aay3224"},{"issue":"3","key":"9759_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","volume":"48","author":"DI Godfrey","year":"2018","unstructured":"Godfrey DI, Le Nours J, Andrews DM, Uldrich AP, Rossjohn J. Unconventional T Cell Targets for Cancer Immunotherapy. Immunity. 2018;48(3):453\u201373.","journal-title":"Immunity"},{"key":"9759_CR17","doi-asserted-by":"crossref","unstructured":"Souter MNT, Awad W, Li S, Pediongco TJ, Meehan BS, Meehan LJ, Tian Z, Zhao Z, Wang H, Nelson A et al. CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells. J Exp Med 2022;219(9):e20210828.","DOI":"10.1084\/jem.20210828"},{"key":"9759_CR18","doi-asserted-by":"publisher","first-page":"860311","DOI":"10.3389\/fimmu.2022.860311","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y, Bian ZH, Yang SY, Wang CB, Li L, Yang YQ, Ansari AA, Gershwin ME, Zeng X, Lian ZX, et al. Single-Cell Characterization of Hepatic CD8(+) T Cells in a Murine Model of Primary Biliary Cholangitis. Front Immunol. 2022;13:860311.","journal-title":"Front Immunol"},{"key":"9759_CR19","doi-asserted-by":"publisher","first-page":"578551","DOI":"10.1016\/j.jneuroim.2025.578551","volume":"400","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sun H, Xu Y, Xuan B, Xia G, Tang J, Lin J, Du A, Sheng H. Identification and characteristics of a novel CD8\u03b1\u03b1 T cell subset in a refractory myasthenia gravis patient. J Neuroimmunol. 2025;400:578551.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"9759_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-3083.2008.02093.x","volume":"67","author":"S Werwitzke","year":"2008","unstructured":"Werwitzke S, Tiede A, Jacobs R, Zielinska-Skowronek M, Buyny S, Schmidt RE, Witte T. CD8\u03b1\u2009+\u2009\u03b2low Effector T Cells in Systemic Lupus Erythematosus. Scand J Immunol. 2008;67(5):501\u20138.","journal-title":"Scand J Immunol"},{"issue":"10","key":"9759_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/0961203319867130","volume":"28","author":"S Minning","year":"2019","unstructured":"Minning S, Xiaofan Y, Anqi X, Bingjie G, Dinglei S, Mingshun Z, Juan X, Xiaohui J, Huijuan W. Imbalance between CD8(+)CD28(+) and CD8(+)CD28(-) T-cell subsets and its clinical significance in patients with systemic lupus erythematosus. Lupus. 2019;28(10):1214\u201323.","journal-title":"Lupus"},{"issue":"1","key":"9759_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae S-C, Boletis J, Bruce IN, Cervera R, Doria A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15\u201329.","journal-title":"Ann Rheum Dis"},{"key":"9759_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fimmu.2013.00223","volume":"4","author":"LJ Walker","year":"2013","unstructured":"Walker LJ, Marrinan E, Muenchhoff M, Ferguson J, Kloverpris H, Cheroutre H, Barnes E, Goulder P, Klenerman P. CD8\u03b1\u03b1 Expression Marks Terminally Differentiated Human CD8\u2009+\u2009T Cells Expanded in Chronic Viral Infection. Front Immunol. 2013;4:223.","journal-title":"Front Immunol"},{"issue":"2","key":"9759_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20171739","volume":"215","author":"G Ben Youssef","year":"2018","unstructured":"Ben Youssef G, Tourret M, Salou M, Ghazarian L, Houdouin V, Mondot S, Mburu Y, Lambert M, Azarnoush S, Diana JS, et al. Ontogeny of human mucosal-associated invariant T cells and related T cell subsets. J Exp Med. 2018;215(2):459\u201379.","journal-title":"J Exp Med"},{"issue":"2","key":"9759_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/blood-2011-05-353789","volume":"119","author":"LJ Walker","year":"2012","unstructured":"Walker LJ, Kang Y-H, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, Sahgal N, Leslie A, Oo Y, Geremia A, et al. Human MAIT and CD8\u03b1\u03b1 cells develop from a pool of type-17 precommitted CD8\u2009+\u2009T cells. Blood. 2012;119(2):422\u201333.","journal-title":"Blood"},{"issue":"1","key":"9759_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-017-1257-5","volume":"19","author":"A Chiba","year":"2017","unstructured":"Chiba A, Tamura N, Yoshikiyo K, Murayama G, Kitagaichi M, Yamaji K, Takasaki Y, Miyake S. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus. Arthritis Res Ther. 2017;19(1):58.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"9759_CR27","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","volume":"193","author":"YN Cho","year":"2014","unstructured":"Cho YN, Kee SJ, Kim TJ, Jin HM, Kim MJ, Jung HJ, Park KJ, Lee SJ, Lee SS, Kwon YS, et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol. 2014;193(8):3891\u2013901.","journal-title":"J Immunol"},{"key":"9759_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3389\/fimmu.2018.01333","volume":"9","author":"A Chiba","year":"2018","unstructured":"Chiba A, Murayama G, Miyake S. Mucosal-Associated Invariant T Cells in Autoimmune Diseases. Front Immunol. 2018;9:1333.","journal-title":"Front Immunol"},{"key":"9759_CR29","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.jtauto.2025.100276","volume":"10","author":"C-x Zhang","year":"2025","unstructured":"Zhang C-x, Mao Y-y, Tan Y-p, Zhang M-y, Shao K, Wang S-j, Ji P, Wang J-y, Yin L, Wang Y. Enhancement of CD8\u2009+\u2009T cell cytotoxicity activity by IFN-\u03b1 implies alternative pathologic role in systemic lupus erythematosus. J Translational Autoimmun. 2025;10:100276.","journal-title":"J Translational Autoimmun"},{"issue":"7","key":"9759_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0961203308089400","volume":"17","author":"A Tulunay","year":"2008","unstructured":"Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E. CD8\u2009+\u2009CD28-, suppressive T cells in systemic lupus erythematosus. Lupus. 2008;17(7):630\u20137.","journal-title":"Lupus"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09759-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:03:21Z","timestamp":1773079401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09759-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9759"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09759-1","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Peking University People\u2019s Hospital (Approval No. 2022PHB346) and was conducted in accordance with the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"23"}}